Instant Quantification

of genetic modifications for Cell and Gene Therapies

With QUiCKR, accelerate programs
in R&D, IND, and Process Development
5X faster while saving 50% on NGS costs

Example use-case: Delivery optimization

Program Duration (Days)

360

Program Testing Cost

$420,000

$210,000

Future Therapy Sales

+30%

NGS

QUiCKR

QUiCKR V2

20 min sample-to-results

High-Throughput
20-150 samples / plate
Automated
0 new instruments required

30,000+ reactions analyzed to date

QUiCKR Workflow

Quantification Using initial CRISPR Kinetic Rates

User Edited Sample

Sample Prep

Plate Transfer

Fluorescent
Readout

Cloud-based
Instant Results

Meet Our Team

We are passionate about accelerating broad access to life saving genetic medicines. Our mission is to engineer tools that test genetic modifications instantaneously. Imagine a world where genetic engineering can iterate as fast as software engineering.

Charles Blanluet

CEO & Cofounder

Stanford Microfludics, Guardant

Prof. Juan Santiago

Scientific Cofounder

Stanford Microfludics, Purigen Biosystems

Jiawei Lee

CBO & Cofounder

UC Berkeley & UCSF, Sequoia

Henrik Sperber

CTO & Cofounder

CRISPR Therapeutics, Paratus Sciences

Prof. Matthew Porteus

Scientific Advisor

Stanford Medicine, CRISPR Therapeutics

Hari Jayaram